United States · Bill · S
S. 1132 (117th)
EPI Act
Introduced
15 April 2021
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Ending Pricey Insulin Act or the EPI Act This bill establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin. Specifically, no private or public health insurance plan may charge an enrollee more than $50 for a 30-day supply of insulin, regardless of the amount of insulin prescribed for that period. This includes any deductible, co-payment, coinsurance, or other cost-sharing requirement. This $50 limit also applies to the cash price for insulin prescriptions for uninsured individuals. The requirements of this bill apply beginning on January 1, 2022, irrespective of the date this bill is enacted.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 15 April 2021
Introduced in Senate (PDF)
Introduced in Senate · EN · 15 April 2021
Introduced in Senate
summary · EN · 15 April 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/senate-bill/1132
- Open data entity: https://api.congress.gov/v3/bill/117/s/1132